Jump to content


Biomarker for Diffuse Scleroderma skin has been discovered!


Photo

Roche Ends Arthritis Drug Trial


  • Please log in to reply
No replies to this topic

#1 janey

janey

    Platinum Member

  • ISN Support Specialists
  • PipPipPipPipPipPipPipPipPipPip
  • 2,118 posts
  • Location:New Mexico

Posted 27 May 2010 - 10:14 AM

Roche Ends Arthritis Drug Trial.

Roche said Wednesday it will discontinue the development of the experimental drug, ocrelizumab, that was designed to treat patients suffering from autoimmune disease rheumatoid arthritis. Roche’s own efficacy and safety analysis of ocrelizumab showed the drug's risk profile to be unfavorable when compared to existing treatments. Goran Mijuk. Wall Street Journal. 05/19/10. (Also see: Rheumatoid Arthritis)

This item was posted in the ISN Newsroom. Check the Newsroom every day for the latest scleroderma medical and support information.
Janey Willis
ISN Support Specialist
(Retired) ISN Assistant Webmaster
(Retired) ISN News Director
(Retired) ISN Technical Writer for Training Manuals
International Scleroderma Network (ISN)